SGA
GMAB icon

Strategic Global Advisors’s Genmab GMAB Stock Holding History

Strategic Global Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,224
Closed -$283K – 146
2025
Q3 		$283K Buy
+9,224
New +$225K 0.04% 129
2024
Q4 		– Sell
-8,320
Closed -$203K – 146
2024
Q3 		$203K Buy
+8,320
New +$222K 0.04% 138
2023
Q1 		– Sell
-4,942
Closed -$209K – 145
2022
Q4 		$209K Buy
+4,942
New +$204K 0.03% 132
2022
Q3 		– Sell
-7,953
Closed -$258K – 146
2022
Q2 		$258K Sell
7,953
-121
-1% -$3.92K 0.04% 138
2022
Q1 		$292K Buy
8,074
+115
+1% +$3.95K 0.04% 128
2021
Q4 		$1.42M Sell
7,959
-31,556
-80% -$1.32M 0.18% 115
2021
Q3 		$1.73M Sell
39,515
-128
-0.3% -$5.75K 0.25% 106
2021
Q2 		$1.62M Buy
39,643
+225
+0.6% +$8.68K 0.29% 110
2021
Q1 		$1.29M Buy
39,418
+106
+0.3% +$3.99K 0.23% 116
2020
Q4 		$1.6M Buy
39,312
+3,349
+9% +$125K 0.28% 105
2020
Q3 		$1.32M Sell
35,963
-257
-0.7% -$9.29K 0.25% 103
2020
Q2 		$1.23M Buy
36,220
+4,060
+13% +$111K 0.26% 98
2020
Q1 		$681K Sell
32,160
-9,202
-22% -$205K 0.18% 108
2019
Q4 		$924K Buy
+41,362
New +$903K 0.19% 113

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Strategic Global Advisors's GMAB Position: Q4 2025 in Review

Strategic Global Advisors sold out of Genmab (GMAB) in Q4 2025, closing a stake of 9,224 shares — an estimated $283K sold.

Strategic Global Advisors first reported a position in GMAB in Q4 2019 and held it in 14 quarters. The position peaked at $1.73M in Q3 2021. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • Strategic Global Advisors reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
  • Strategic Global Advisors sold 9,224 Genmab shares in Q4 2025, an estimated $283K.
  • Strategic Global Advisors first reported a position in Genmab in Q4 2019 and held it in 14 quarters.
  • Strategic Global Advisors's Genmab position peaked at $1.73M in Q3 2021.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Strategic Global Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.